Asian press release distribution

Press Releases for Thursday, August 12, 2021

Bitcoin Latinum與世界知名的The h.wood集團合作進行區塊鏈擴展 22:00 HKT/SGT

Bitcoin Latinum与世界知名的The h.wood集团合作进行区块链扩展 22:00 HKT/SGT

Bitcoin Latinum Partners with World Famous The h.wood Group for Blockchain Expansion 22:00 HKT/SGT

ClearSight Announces Release of New Job Platform Based on Cryptocurrency 22:00 HKT/SGT

高阳科技2021年上半年经调整净利增40%至港币3.12亿元 21:10 HKT/SGT

高陽科技2021年上半年經調整淨利增40%至港幣3.12億元 21:07 HKT/SGT

HKTDC Food Expo and concurrent fairs open today 20:00 HKT/SGT

HKTDC Food Expo and concurrent fairs open today 19:00 HKT/SGT

Windfall Announces Its Listing in August 18:00 HKT/SGT

Sunpower's GI business performed well in 1H 2021 with GI PATMI up 37.0% YoY to RMB91.8 million 18:00 HKT/SGT

아방스 클리니컬, 고객 가치 리더십 부문에서 프로스트&설리번 2021 아시아-태평양 CRO 최고기업상 수상 16:30 HKT/SGT

Wintermar Offshore (WINS:JK) Reports 1H2021 Results 16:30 HKT/SGT

增程式电动汽车先锋理想汽车今日上市一季度营收增幅超300% 16:00 HKT/SGT

增程式電動汽車先鋒理想汽車今日上市一季度營收增幅超300% 16:00 HKT/SGT

The Return of China's Overseas-listed NEV Companies Accelerates with Li Auto's Dual Primary Listing in Hong Kong 16:00 HKT/SGT

Synopsis 2021: Edition III to air September 20-24 13:00 HKT/SGT

Newly-formed Labuan Economic Sector Coalition urges federal gov to begin dialogue to formulate fair SOP 11:00 HKT/SGT

エーザイ、「レンビマ(R)」と「キイトルーダ(R)」の併用療法による成人の進行性腎細胞がん一次治療に関する承認を米国FDAより取得 09:00 HKT/SGT

FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for First-Line Treatment of Adult Patients with Advanced Renal Cell Carcinoma (RCC) 08:31 HKT/SGT

A new book, "How To Talk To Strangers" by Kerrie Phipps, launched to help people decrease anxiety, build confidence, and heal the pandemic affected world 08:00 HKT/SGT

ACN Search:

Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575